Johnson & Johnson Ends 2011 Just At It Began — By Recalling More Stuff

Johnson & Johnson Ends 2011 Just At It Began — By Recalling More Stuff

After more than a year of near-constant recalls, the folks at Johnson & Johnson’s McNeil Labs aren’t finished yet. This time, it’s a mere 12 million bottles of Motrin that are being recalled from store shelves because the pills may not dissolve as quickly as they are supposed to. [More]

$10M Awarded After Child Got Skin Burns On 85% Of Body After Taking Motrin

$10M Awarded After Child Got Skin Burns On 85% Of Body After Taking Motrin

A jury has awarded the family of a child $10 million after she developed skin burns on 85% of her body after taking Children’s Motrin. [More]

Oregon Sues J&J For Secretly Recalling Motrin

Oregon Sues J&J For Secretly Recalling Motrin

Instead of issuing a recall, after Johnson and Johnson discovered its Motrin caplets were defective, they hired a contractor to go around the country buy up all the drugs. It was a “secret recall” that left the bad medicine on shelves for months for consumers to buy. Now the Oregon AG is suing J&J. The story broke when one of the guys hired to do the buying faxed regulators the instructions J&J gave him. [More]

Recalls Issued For Children's Benadryl, Motrin & Rolaids Softchews

Recalls Issued For Children's Benadryl, Motrin & Rolaids Softchews

Johnson & Johnson continues to earn its title as the recall king of the over-the-counter drug business with the announcement of three separate recalls totaling around 5 million units of Children’s Benadryl Allergy Fastmelt Tablets, Junior Strength Motrin Caplets, and Extra Strength Rolaids Softchews. [More]

Johnson & Johnson Hired Fake Shoppers To Buy Up Bad Motrin, Avoid Public Recall

Johnson & Johnson Hired Fake Shoppers To Buy Up Bad Motrin, Avoid Public Recall

Ever since the FDA and Congress started asking Johnson & Johnson to explain why it keeps recalling medicine, there have been references to an unpublicized “recall” that happened in November 2008. Last month, at a hearing of the House Oversight and Government Reform Committee, a J&J executive swore that the company didn’t mean to mislead anyone. It turns out that wasn’t exactly accurate: Bloomberg has obtained emails from J&J’s company, McNeil Consumer Healthcare, that show executives knew the secret recall would trigger an FDA reaction if the agency got wind of its full scope. [More]

Tylenol Recall Factory Was Staffed With Undertrained Temps

Tylenol Recall Factory Was Staffed With Undertrained Temps

The manufacturing plant that has been the cause of Johnson & Johnson’s latest in a string of recalls has already been described as dirty and poorly maintained. It turns out that it was also staffed with temps and contract employees who weren’t properly trained, according to tax records and an FDA inspection report filed earlier this year. [More]

FDA Announces Widespread Investigation Of McNeil After Tylenol Recalls

FDA Announces Widespread Investigation Of McNeil After Tylenol Recalls

Remember the recalled liquid Tylenol and other children’s medicines last month? Or the stinky drugs that were recalled back in January? Or the children’s Tylenol that was recalled last September? The FDA remembers, which is probably why it’s “conducting a company-wide investigation of McNeil Consumer Healthcare’s drug manufacturing practices to determine whether similar problems exist throughout the company.” Also, a date has now been set (May 27) for the House Committee hearing where the CEO and chairman of parent company Johnson & Johnson are expected to testify. [More]

Congress Opens Investigation Into Children's Tylenol Recall

Congress Opens Investigation Into Children's Tylenol Recall

The House Committee on Oversight and Government Reform — the same crew behind the Toyota recall hearings — has announced that it has opened an investigation into the recent recall of Children’s Tylenol and several other brands of kids’ medicine. [More]

Children's Tylenol, Motrin, Other Medications Recalled

Children's Tylenol, Motrin, Other Medications Recalled

Head to your medicine cupboards and start checking out the children’s meds you might have there — the Food and Drug Administration announced today Johnson & Johnson’s McNeil Consumer Healthcare Unit has begun a voluntary recall of various medicines because of manufacturing discrepancies. [More]

FDA Is Mad: Funky, Smelly, Barfy Tylenol Has Been A Problem Since 2008

FDA Is Mad: Funky, Smelly, Barfy Tylenol Has Been A Problem Since 2008

The FDA is @#$%# pissed off at McNeil, the company that makes smelly, barfy Tylenol and other products, because apparently this problem has been going on since 2008. [More]

Tylenol Recall Now Includes A Bunch Of Other Products

Tylenol Recall Now Includes A Bunch Of Other Products

Some batches of a certain type of Tylenol had an unusual moldy, musty, or mildew-like odor that is associated with non-serious nausea, stomach pain, vomiting, or diarrhea. The smell is apparently from a chemical that was on the wood pallets the pills were stored on. Originally, the recall was just for one type of Tylenol. Now there is a big ass list, which includes some types of Motrin, Rolaids and St. Joseph brand products. [More]

Controversial Ad Implies Celebrex Is As Safe As OTC Painkillers

Controversial Ad Implies Celebrex Is As Safe As OTC Painkillers

A new ad for Celebrex, a prescription painkiller related to Vioxx, has come under fire for implying that Celebrex is as safe as non-prescription painkillers such as ibuprofen (Advil, Motrin) and naproxen (Aleve.) A consumer group has written a letter to the FDA requesting that they ban the ad, claiming that it contains “false or misleading statements.”

“The overall purpose of the ad is to make it appear, contrary to scientific evidence, that the cardiovascular dangers of Celebrex are not greater than those of any of the other Nsaid painkillers,” the letter said, referring to nonsteroidal anti-inflammatory drugs. “Further, it asserts that certain gastrointestinal problems are, if anything, less frequent with Celebrex than with two popular over-the-counter (OTC) painkillers.”

The ad, which is two-and-a-half minutes long (Pfizer was the only sponsor of the program on which it aired), can be viewed at Celebrex.com. The ad marks Celebrex’s return to advertising after a two year hiatus following Vioxx’s withdrawal from the market due to dangerous cardiovascular side-effects.

FDA Calls For Stricter Warnings on Tylenol and Other OTC Drugs

“Non-prescription pain relievers used by millions of U.S. consumers need stronger health warnings regarding liver or stomach risk, the Food and Drug Administration said Tuesday.” The drugs in questions are acetaminophen (Tylenol), and NSAIDs like ibuprofen (Advil, Motrin). In particular acetaminophen is associated with liver problems.